InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 43.50
-1.10 (-2.47%)
Last updated: Jul 24, 2025
InventisBio Market Cap
InventisBio has a market cap or net worth of 25.53 billion as of July 25, 2025. Its market cap has increased by 512.22% in one year.
Market Cap
25.53B
Enterprise Value
23.92B
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.50
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 25.53B, an increase of 190.36%. That is a compound annual growth rate of 42.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 25.53B | 232.79% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 375.59B |
| Shenzhen Mindray Bio-Medical Electronics | 280.39B |
| WuXi AppTec | 253.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.97B |
| Sichuan Biokin Pharmaceutical | 122.14B |
| Aier Eye Hospital Group | 121.87B |
| Shanghai United Imaging Healthcare | 112.42B |
| Yunnan Baiyao Group Co.,Ltd | 100.86B |